Cell & Gene Therapy International Europe 2027
Cell & Gene Therapy International Europe is a Berlin conference and exhibition on developing, manufacturing and commercializing cell and gene therapies. It's attended by biotech and pharma executives, scientists, manufacturing and regulatory specialists.
Dates not announced yet
Check the official site for updates
Organizer
Published by the organizer
Every year
How often it's held
Checked November 6, 2026
Reported attendance
200+
global scientists · 2025
Reported exhibitors
Not published
About Cell & Gene Therapy International Europe 2027
Cell & Gene Therapy International Europe is Informa Connect's conference and exhibition on making cell and gene therapies at commercial scale. It's aimed at therapy developers, manufacturing and analytical teams, regulatory specialists and investors. The latest edition ran from 3 to 5 November 2026 at Hotel Palace Berlin. The organizer invites visitors to sign up for 2027 updates, but it hasn't announced 2027 dates or a venue yet. It reported 200+ attendees from 150+ companies at the 2025 meeting.
What happens at Cell & Gene Therapy International Europe
The event combines a conference, an exhibit hall and partnering meetings over three days. The 2026 agenda opened on 3 November with a full-day workshop on manufacturing tech transfer. The main conference ran on 4 and 5 November.
Day one of the 2026 conference started with a keynote plenary and a keynote investor panel. Parallel streams then covered cell therapy manufacturing and analytics, and gene therapy manufacturing and analytics. A networking reception in the exhibit hall closed the day.
Day two added innovation showcases for young cell therapy and gene therapy companies, plus poster viewing. During lunch, Live Labs offered 10-minute product demos at exhibitor booths.
In 2026, two co-located events shared the venue. They were Exosomes Europe and LNPs Europe, which covers lipid nanoparticle delivery. The organizer hasn't said whether the 2027 program keeps the same format.
What's new at Cell & Gene Therapy International Europe 2027
The organizer hasn't announced anything new for 2027 yet. Its event site only offers a sign-up for 2027 updates.
The 2026 edition moved from December to November and to a new Berlin venue. Evotec's 2025 event page shows the previous edition ran from 1 to 3 December 2025. The Start-Up Zone and the exosome and LNP tracks were new in 2026.
Related events on this site include BioProcess International Europe 2027, BIO-Europe Spring 2027 and BIO-Europe 2026.
Who attends Cell & Gene Therapy International Europe
Most attendees work at companies developing cell and gene therapies. The organizer says the event suits professionals in development, manufacturing, analytics, regulatory affairs and commercialization. It names CEOs, CSOs, CBOs, CMOs, scientists, engineers and consultants.
For the 2025 meeting, the organizer reported 200+ scientists, executives and technology leaders. They came from 150+ companies, and 65% of those companies were cell and gene therapy developers.
The organizer hasn't published attendance figures for the November 2026 edition. Before the show, it promoted 70+ speakers, 100+ companies and 20+ exhibitors. Those were targets, not results.
The 2026 program also drew investors and regulators. Venture firms sat on the keynote investor panel, and the Alliance for Regenerative Medicine spoke on European regulation.
Attendance and exhibitors by year
As the organizer reports them. What's counted varies between events, so compare with care.
| Edition | Attendance |
|---|---|
| 2025 | 200+global scientists, executives and technology leaders (organizer figure)Organizer's figure for the 2025 meeting in Berlininformaconnect.com ↗ |
Companies exhibiting and speaking at Cell & Gene Therapy International Europe 2026
No companies have been announced for 2027 yet. The sponsor page named six sponsors and exhibitors, three media partners and two promotional participants for 2026. Speakers came from big pharma, commercial cell and gene therapy companies, and start-ups.
Partners (5)BioPharma Asia, European Pharmaceutical Manufacturer, Gene Therapy Net and 2 more
Exhibitors (6)Catalent, Chromagenix, Clean Biologics and 3 more
- Catalent · 2026Listed under Conference Sponsors & Exhibitors
- Chromagenix · 2026Listed under Conference Sponsors & Exhibitors
- Clean Biologics · 2026Listed under Conference Sponsors & Exhibitors
- NanoEntek EU · 2026Stand 5, Live Labs demo
- NanoFcm · 2026Listed under Conference Sponsors & Exhibitors
- Terumo BCT Europe N.V. · 2026Stand 4, Live Labs demo
Speakers' companies (12)Orchard Therapeutics, Legend Biotech, Johnson & Johnson Innovative Medicine and 9 more
- Orchard Therapeutics · 2026Opening plenary talk
- Legend Biotech · 2026Commercial CAR-T production talk
- Johnson & Johnson Innovative Medicine · 2026Lentiviral vector network talk
- CSL Behring · 2026Hemgenix potency case study
- Novartis · 2026Cell therapy quality talk
- Sensorion · 2026Dual AAV vector talk
- Genethon · 2026Upstream AAV production talk
- Bayer · 2026Chairs the keynote plenary
- UCB · 2026Gene therapy downstream processing talks
- BlueRock Therapeutics · 2026Cell therapy analytics talk and track chair
- Autolus Therapeutics · 2026Cell therapy scale-up talk
- Alliance for Regenerative Medicine · 2026European regulatory landscape talk
Big pharma names on the 2026 agenda included Novartis, Johnson & Johnson Innovative Medicine, Bayer, UCB and CSL Behring. Commercial therapy companies included Legend Biotech, Autolus Therapeutics and Orchard Therapeutics.
Exhibitors at Cell & Gene Therapy International Europe
The organizer hasn't published an exhibitor count for 2026 or opened 2027 exhibitor bookings on its site. Its sponsor page named six sponsors and exhibitors for 2026 on 25 October 2026, by our count. They were Catalent, Chromagenix, Clean Biologics, NanoEntek EU, NanoFcm and Terumo BCT Europe.
A Start-Up Zone was new on the 2026 exhibition floor. The Full Package cost £3,000 plus VAT. It included a 2 by 2 meter tabletop, a quick pitch and one main conference pass.
The 2026 Full Package Plus cost £4,500 plus VAT and included two passes. Applicants had to be under five years old with fewer than ten employees.
Sponsors and exhibitors get Lead Insights, a lead scoring and reporting dashboard for their delegate interactions. Compare options in our guides to lead retrieval apps and meeting scheduling software.
Sponsors and partners at Cell & Gene Therapy International Europe
Sponsorship is sold as custom packages, according to the homepage FAQ. The Why Sponsor page lists speaking sessions, branded items, exhibit booths and private meeting rooms.
The sponsor page listed BioPharma Asia, European Pharmaceutical Manufacturer and Gene Therapy Net as 2026 media partners. Bio Partner and MaxCyte were listed as 2026 promotional participants.
The sponsorship prospectus sits behind a request form on the organizer's site. For tools that track packages and deliverables, see our event sponsorship software guide.
The event's tech
We couldn't identify a third-party registration platform on the event's website.
Cell & Gene Therapy International Europe attendee list, exhibitor list and sponsor list
Exhibitor list
Published
Sponsor list
Published
Attendee list
Not published or sold
The organizer doesn't publish a full attendee list on its site. Its snapshot attendee list sits behind a sign-up form.
Registered attendees get the full attendee list inside the ConnectMe app, with messaging and meeting requests. The registration page says this covers both in-person and digital attendees.
Exhibitors, sponsors and media partners appear on the official sponsors and exhibitors page. The site doesn't carry a separate exhibitor directory or a public floor plan.
The organizer warns about housing companies that aren't affiliated with the event. It says official hotel links appear only on its own website. Read how to find who's attending an event and our roundup of event intelligence platforms.
See who's attending Cell & Gene Therapy International Europe
Organizers don't publish attendee lists. These event intelligence platforms show which companies and roles are likely to attend and help you book meetings. How to find who's attending
Speakers at Cell & Gene Therapy International Europe 2027
Cell & Gene Therapy International Europe hasn't announced its 2027 speakers yet. The organizer's event site offers 2027 updates by email sign-up.
Cell & Gene Therapy International Europe hasn't announced its 2027 speakers yet. Below is who spoke at past editions.
At the 2026 edition, Gunther Busam of Orchard Therapeutics gave the opening plenary talk on 4 November. Marion Hitchcock of Bayer chaired the plenary.
The 2026 keynote investor panel featured Novo Nordisk Foundation Cellerator, LongeVC, High-Tech Gründerfonds, Avant Bio and Advantary Capital Partners. Sarah Snykers of Legend Biotech and Rutger Douma of Johnson & Johnson spoke in the manufacturing tracks.
On 5 November 2026, Simone Zanetti of CSL Behring presented a Hemgenix case study. Paolo Morgese of the Alliance for Regenerative Medicine covered European regulation.
Two innovation showcases featured young companies in 2026. Presenters included Captain T Cell, ImmunoKey, NeutroGen Therapeutics, Ikarovec, Kindling Bio, EpiBlok Therapeutics and CREATe Therapeutics. Researchers could add a scientific poster to an All Access pass.
Who spoke at Cell & Gene Therapy International Europe 2026 (38)
- Gunther Busam, Vice President, Global Manufacturing Technology and Supply, Orchard Therapeutics
- Marion Hitchcock, Managing Director Gene and Cell Therapies Incubator Berlin, R&D Strategy and Portfolio Manager, Bayer
- Bo Wiinberg, Chief Business Development Officer, Novo Nordisk Foundation Cellerator
- Artemy Shumskiy, Principal, LongeVC
- Christian Kannemeier, Senior Investment Manager, High-Tech Gründerfonds Management GmbH
- Ole Henrik Bang-Andreasen, Principal, Avant Bio
- Gadareth Higgs, Head Healthcare and Life Sciences Partner, Advantary Capital Partners
- Sarah Snykers, Head of Site Strategy and Excellence, Legend Biotech
- Simone Zanetti, Global Head of QC Analytical Technologies, Gene Therapy, CSL Behring
- Rutger Douma, MSAT Advanced Therapies Director, Johnson & Johnson Innovative Medicine
- Christine Le Bec, Deputy CTO, Head of Analytical Development and QC, Sensorion
- Parag Kumthekar, Lead Gene Therapy Downstream Process Development, UCB
- Nicole Lund, Senior Director of Analytical and Quality Control, BlueRock Therapeutics
- Ketki Flannery, Associate Director MSAT and CMC, Autolus Therapeutics
- Sima Hirani, Field Application Scientist, Cell Therapy, Catalent Pharma Solutions
- Anette Brass, Head of Process Development, Anocca AB
- Volker Huppert, Chief Development Officer, Glycostem Therapeutics
- Ramiz Saramati, QA Operations Expert, Novartis
- Clotilde Ciesla, Upstream Development Engineer, Genethon
- Jordan Turnbull, Co-Founder, Co-CEO, CSO, Fuse Vectors
- Jelmer Willems, Senior Scientist, Group Leader, Vector Development, VectorY
- Nic Preyat, Associate Director, Process Sciences, CMC Development, Gene Therapy, UCB
- Céline Jaudouin, Senior Formulation Scientist, Alaya.bio
- Lorenz Mayr, Managing Director, BioMedTech Consulting GmbH
- Matthias Bozza, Director, Head of Strategy and R&D, CPTx
- Ulf Grawunder, Co-founder and CEO, T-CURX
- Rolando Matos, Senior Scientist, Cell and Gene Therapy Catapult
- Stefan Bostock, CEO and Co-Founder, Danu Insights
- Paolo Morgese, VP Public Affairs EMEA, Alliance for Regenerative Medicine
- Stephanie Sontag, Senior Research Scientist, Evotec International GmbH
- Alberto Sada Japp, Senior Director, R&D, Captain T Cell
- Gray Kueberuwa, Chief Executive Officer, ImmunoKey Ltd
- Lorenz Knackstedt, Chief Technology Officer, NeutroGen Therapeutics
- Andy Osborne, Vice President of Pre-Clinical Research, Ikarovec
- Aleck Jones, CEO, Kindling Bio
- Regine Heilbronn, Co-Founder and CEO, EpiBlok Therapeutics
- Tamás Kitka, Founder, Managing Director, CREATe Therapeutics
- Thomas Chattaway, Senior Life Science Consultant
Dates, venue and getting there
Dates and a venue for 2027 aren't announced yet. The organizer's event site thanks 2026 attendees and offers sign-up for 2027 updates.
The 2026 edition ran from 3 to 5 November 2026 at Hotel Palace Berlin. That hotel is at Budapester Straße 45 in the city's west. The visitBerlin convention office lists 2,600 square meters of event space and 18 function rooms.
The 2025 edition took place at the Mercure Hotel MOA in Berlin from 1 to 3 December 2025. Both of the last two editions were in Berlin.
Tickets and registration for Cell & Gene Therapy International Europe
Registration is paid and priced by company type. Prices for 2027 aren't published yet. In October 2026, the Biopharma, Academic and Government conference pass cost £1,199 plus 19% VAT. Adding the workshop raised it to £1,399 plus VAT.
For 2026, biopharma rates required a cell or gene therapy product in the pipeline. CDMOs, CROs, suppliers and sales staff had to book the Service Provider rate.
Start-up rates applied to therapy developers under five years old with fewer than ten employees. Groups of three to four got 10% off, and groups of five to nine got 15% off.
Passes included 12 months of on-demand access to recorded main conference talks. A Digital Experience pass covered virtual attendance.
Resources for exhibitors, sponsors and attendees
These official pages cover the latest edition and how to follow plans for 2027.
- Event siteWith the sign-up for 2027 updates.
- 2026 agendaWith workshops, tracks and showcases by day.
- 2026 speakersAcross all tracks and co-located events.
- Sponsors and exhibitorsListed for the 2026 edition.
- Why sponsorFor sponsorship formats and the prospectus request.
- Start-Up ZoneFor tabletop packages for young companies.
- Registration pageFor delegate rates and what each pass includes.
- ConnectMe appFor networking and meeting requests.
- Hotel fraud advisoryOn unofficial housing companies.
- Visitor information on the 2026 venueFrom visitBerlin.